EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Exercise as a Metabolic Therapy for MASLD: Beyond Weight Loss Toward Sustainable Exercise Strategies

Hee-Tae Roh iD, Ju-Yong Bae iD

Medicina · 18.04.2026 · 62 (4) · 784

DOI: 10.3390/medicina62040784 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Medicina, online erschienen am 18.04.2026. Verfasst von Hee-Tae Roh und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Sports Science, College of Arts and Sports, Sun Moon University, Asan-si 31460, Republic of Korea. Hauptthemen laut MEDLINE: Exercise, Fatty Liver, Exercise Therapy, Metabolic Diseases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 128 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Dong-A University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Metabolic dysfunction–associated steatotic liver disease (MASLD) is a systemic metabolic disorder characterized by impaired metabolic flexibility involving the liver, skeletal muscle, and adipose tissue. Although weight loss has traditionally been emphasized in its management, emerging evidence suggests that exercise exerts therapeutic effects beyond body weight reduction. This narrative review aims to examine exercise as a metabolic therapy for MASLD by integrating mechanistic insights and clinical evidence. Exercise improves hepatic steatosis, insulin resistance, mitochondrial function, and inflammatory signaling through interconnected pathways, including activation of AMPK-related signaling, enhanced fatty acid oxidation, and muscle–liver crosstalk mediated by myokines. Importantly, these benefits can occur independently of weight loss, supporting a shift from weight-centered to metabolism-focused treatment strategies. Both aerobic and resistance exercise demonstrate efficacy, with combined approaches providing complementary benefits. In conclusion, exercise should be considered a central therapeutic strategy for MASLD by restoring metabolic flexibility rather than solely promoting weight reduction. Future research should focus on optimizing individualized and sustainable exercise prescriptions to enhance long-term clinical outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ExerciseFatty LiverExercise TherapyMetabolic DiseasesHumansWeight LossInsulin Resistance

Stichwörter der Autor:innen

aerobic exerciseexercise therapyhepatic steatosisinsulin resistancemetabolic adaptationmetabolic dysfunction–associated steatotic liver disease (MASLD)resistance training

Autor:innen und Institutionen

  • Department of Sports Science, College of Arts and Sports, Sun Moon University, Asan-si 31460, Republic of Korea.
  • Department of Physical Education, College of Arts and Sports, Dong-A University, Busan 49315, Republic of Korea.

ORCID-Profile: Hee-Tae Roh, Ju-Yong Bae

Förderung

  • Dong-A University

Zitieren

APA

Roh, H. T., & Bae, J. Y. (2026). Exercise as a Metabolic Therapy for MASLD: Beyond Weight Loss Toward Sustainable Exercise Strategies. Medicina, 62(4), 784. https://doi.org/10.3390/medicina62040784

Vancouver

Roh HT, Bae JY. Exercise as a Metabolic Therapy for MASLD: Beyond Weight Loss Toward Sustainable Exercise Strategies. Medicina. 2026;62(4):784. doi:10.3390/medicina62040784

BibTeX
@article{Roh2026,
  author = {Roh, Hee-Tae and Bae, Ju-Yong},
  title = {Exercise as a Metabolic Therapy for MASLD: Beyond Weight Loss Toward Sustainable Exercise Strategies},
  journal = {Medicina},
  year = {2026},
  volume = {62},
  number = {4},
  pages = {784},
  doi = {10.3390/medicina62040784}
}
Kostenlos starten →